Steven Altschuler

Dr. Steven M.
Altschuler, MD, is a Chairman at Azura Ophthalmics Ltd., a Chairman at Lexeo Therapeutics, Inc., a Chairman at AsclepiX Therapeutics LLC, a Managing Director-Healthcare Ventures at Ziff Capital Partners LLC, a Chairman at Stellular Bio, Inc., a Chairman & Chief Executive Officer at Corner Therapeutics, Inc., a Chief Executive Officer & Director at ai3Bio, an Independent Trustee at Brigham & Women's Physician Group and an Independent Trustee at The Brigham & Women's Hospital, Inc. He is on the Board of Directors at ai3Bio, Affinivax, Inc., Free Library of Philadelphia, Imvax, Inc., Innovative Genomics Institute, The GAVI Campaign, Brigham & Women's Physician Group and The Brigham & Women's Hospital, Inc. Dr. Altschuler was previously employed as a Chairman by 89bio, Inc., an Independent Director by Orchard Therapeutics Plc, an Independent Director by Adtalem Global Education, Inc., an Executive Vice President-Healthcare by Miami University, a President & Chief Executive Officer by University of Miami Health System, a Chairman by Spark Therapeutics, Inc., an Independent Director by WW International, Inc., an Independent Director by Mead Johnson Nutrition Co., a Chief Executive Officer by The Children's Hospital of Philadelphia, a President & Chief Executive Officer by The Children's Hospital of Philadelphia Foundation, and a Chairman-Pediatrics Department & Faculty Member by Perelman School of Medicine.
He also served on the board at Mead Johnson Nutrition Co., Children's Miracle Network and University Healthsystem Consortium, Inc. He received his undergraduate degree from Case Western Reserve University and a doctorate degree from Case Western Reserve University.